Board of Directors

Management

Board of Directors

James S. Kuo, M.D., M.B.A.

Chairman of the Board and Chief Executive Officer

Dr. Kuo is Duska’s Chairman and Chief Executive Officer. Previously, he was Chairman and Chief Executive Officer of BioMicro Systems, Inc., a private, venture-backed and profitable life science company. While at BioMicro, he led distribution, marketing and sales of the company’s MAUI™ product line. Prior to that time, Dr. Kuo was President, and Chief Executive Officer of Discovery Laboratories, Inc., where he raised over $22 million in initial private funding and took the company public. Dr. Kuo is the former Managing Director of Venture Analysis for HealthCare Ventures, LLC, which managed $378 million in venture funds. He has also been a senior pharmaceutical licensing and development executive at Pfizer, Inc., and Vice President of Business Development at Myriad Genetics, Inc. Dr. Kuo is a Board Director of Monarch Labs, LLC, Chairman of the Board of DOR BioPharma, Inc., and a Board Director of Adeona Pharmaceuticals, Inc. After studying molecular biology and receiving his B.A. at Haverford College, Dr. Kuo simultaneously received his M.D. from The University of Pennsylvania School of Medicine and his M.B.A. from The Wharton School of Business at the University of Pennsylvania.

H. David Coherd

Director

Mr. Coherd is Senior Managing Director and head of Investment Banking for RedChip Capital, LLC, the investment banking arm of RedChip Companies. He is also the managing member of BioMed Cap, LLC, a firm focused on life science investing. Mr. Coherd is a business leader with over 18 years' experience in investment banking with a major focus in life sciences and healthcare. He has co-founded three successful boutique investment banking firms: Perpetual Growth Advisors, LLC, Cardinal Securities, LLC and most recently, Growth Capital Partners, LLC. Previously, Mr. Coherd was a Vice-President at Josephthal & Co. and JW Charles Securities, where he was involved in over 25 IPOs in life sciences and other areas. He graduated cum laude from Georgia State University with a B.B.A. in Economics.

Steven Dinh, Sc.D.

Director

Dr. Dinh has been an executive in the pharmaceutical industry for more than 20 years. Most recently, he served as Vice President of Research and Technology Development at Emisphere Technologies, Inc. Previously, he served as Chief Scientific Officer at Lavipharm, and as Head of Transdermal Pharmaceutical R&D at Novartis Pharmaceuticals Corp. Dr. Dinh graduated from the Massachusetts Institute of Technology with a Sc.D. degree in Chemical Engineering.

Shepard Goldberg

Director

Mr. Goldberg was recently Senior Vice President, Operations and Office of the President, at Emisphere Technologies, Inc. Emisphere is a publicly traded biopharmaceutical company charting new frontiers in drug delivery. Prior to joining Emisphere, Mr. Goldberg was President of Hydrovalve Co. Inc., a privately held manufacturing/distribution business with national and Canadian catalog sales. Mr. Goldberg currently serves on the board of Ortec International, Inc. He received his B.S. in Electrical Engineering and Computer Sciences from the Polytechnic Institute in New York City and a M.B.A. in Marketing from Adelphi University.

Manuel P. Graiwer, Esq.

Director

Mr. Graiwer is a managing director of Graiwer & Kaplan, a professional corporation in Los Angeles, California. Since 1994, Mr. Graiwer has led a private venture capital group focusing on small cap biopharmaceutical companies. Mr. Graiwer received his B.Sc. degree from the University of California in Los Angeles and J.D. from the University of California, Davis, School of Law. In 1975, Mr. Graiwer was admitted to present arguments in front of the Supreme Court of the United States. He was former Pro Tempore Judge for the Workers Compensation Appeals Board and an Arbitrator of the American Arbitration Association. Mr. Graiwer is a member of the California Bar Association, California Trial Lawyers and California Applicant Attorney Association.

Philip A. Sobol, M.D.

Director

Dr. Sobol is a practicing orthopedic surgeon who is the managing director of Sobol Orthopedic Medical Group, Inc., of Southern California. Dr. Sobol is certified by the American Board of Orthopedic Surgery and a Fellow of the American Academy of Orthopedic Surgery. Since 2004 he has been a member of S&B Surgery Center Board of Directors, and from 1984 until 1993 he was an Assistant Clinical Professor at the University of Southern California. Dr. Sobol received his B.A. degree from the University of Rochester, Rochester, New York and his M.D. from the University of Southern California, Los Angeles, California.

Alan Tuchman, M.D.

Director

Dr. Tuchman is Executive Chairman of Neurophysics, Inc., a medical technology company. He is also a partner in Xmark Opportunity Partners, a biotech investment fund. Dr. Tuchman is Clinical Professor of Neurology and Pharmacology at New York Medical College and the author of over 30 scientific papers and book chapters. He serves on the Scientific Advisory Board of Oncolytics Biotech, Inc., and was previously the President of the Epilepsy Society of Southern New York as well as Vice Dean for Clinical Affairs at New York Medical College. Dr. Tuchman received his M.D. from the University of Cincinnati, College of Medicine, and completed his neurology residency at the Mt. Sinai School of Medicine. He received his M.B.A. from Columbia University.

Duska Therapeutics

info@duskatherapeutics.com

At the heart of cardiovascular medicine